This is the authors' abstract. We don't add key points for this paper.
A mechanically adjustable reinforced thermoplastic superelastomer system, with tunable gas-permeability, was developed. The superelastomer is based on a graft copolymer structure, using commercial butyl rubbers (or poly(isobutylene- co -isoprene), P(IB- co -I)) and l - or d, l -lactide (LLA or LA) derived from renewable feedstocks, by a “grafting from” controlled polymerization. First, hydroxyl-functionalized PIB (PIB- g -(OH)) macroinitiators were prepared through epoxidation using an economical alternative to m -chloroperoxybenzoic acid and ring-opening reaction. Second, PIB-based graft copolymers with end-hydroxylated poly(lactide) as hard side-chains, PIB- g -(P(L)LA–OH)s, were synthesized to target f P(L)LA of 0.18–0.45, to achieve mechanical reinforcement and an additional gas barrier. They were subsequently acetylated with an acetic anhydride to produce PIB- g -(P(L)LA–Ac)s with improved thermal stability. The well-defined molecular structures indicated controlled P(L)LA lengths, and the resulting superelastomers demonstrated improved thermal stability with increased T d,5%; microphase-separated structures having spherical and/or elongated features; thermoplastic behaviors proved by T ODT, which were much lower than the resulting T d,5%; and superior and adjustable mechanical characterizations, proving to control elastomeric-to-ductile properties. An oxygen permeability value as low as 27 mL mm m –2 day –1 atm –1 was achieved by increasing f P(L)LA to 0.45, comparable to polyethylene terephthalate. The partially biodegradable and processable gas barrier films based on these PIB- g -PLLA thermoplastic superelastomers have great potential for the flexible packaging of food and medical products.
No takes yet. Share an insight, caveat, or question.
Yuk et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: